InMed Pharmaceuticals Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
InMed Pharmaceuticals Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q4 2023.
  • InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $18.3K, a 74.1% decline year-over-year.
  • InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $134K, a 76% decline year-over-year.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $138K, a 50.5% decline from 2023.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $278K, a 60.1% decline from 2022.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $698K, a 14.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $134K $18.3K -$52.4K -74.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $187K $25.2K -$91.5K -78.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $278K $40.5K -$136K -77.1% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 $415K $50.4K -$145K -74.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $559K $70.6K -$144K -67.1% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $703K $117K +$5.54K +4.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $698K $177K -$44K -19.9% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-29
Q1 2022 $742K $195K -$12.2K -5.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $754K $215K +$118K +122% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-17
Q3 2021 $636K $111K +$25.7K +30.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $610K $221K +$64.8K +41.5% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-23
Q1 2021 $545K $207K +$3.43K +1.68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $542K $96.6K -$187K -66% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $729K $85.4K -$265K -75.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $994K $156K Apr 1, 2020 Jun 30, 2020 10-K 2021-09-24
Q1 2020 $204K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $284K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $350K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.